Ectyoplasides AϪB Ϫ Unique Triterpene Oligoglycosides
hydrogen atoms were kept fixed using the SHAKE algorithm. The 2.12 (7ax-H, overlapped), 2.11 (15a-H, overlapped), 2.05 (7eq-H,
FULL PAPER
coordinates produced by the simulation were saved every 0.5 ps,
giving 250 structures. Each of these was subjected to energy minim-
ization using the conjugated gradient protocol.
overlapped), 2.03 (16a-H, overlapped), 2.00 (12eq-H, overlapped),
1.92 (2eq-H, overlapped), 1.90 (dd, J ϭ 10.5, 8.2, 12ax-H), 1.85
(1ax-H, overlapped), 1.85 (6ax-H, overlapped), 1.79 (d, J ϭ 8.9,
6eq-H), 1.73 (br. s, 27-H3), 1.66 (br. s, 26-H3), 1.66 (15b-H, over-
lapped), 1.56 (dd, J ϭ 7.2, 5.0, 17-H), 1.47 (dd, J ϭ 7.0, 5.0, 20-
H), 1.38 (br. s, 29-H3), 1.34 (5-H, overlapped), 1.33 (16b-H, over-
lapped), 1.26 (1eq-H, overlapped), 1.12 (br. s, 19-H3), 0.93 (d, J ϭ
7.0, 21-H3), 0.67 (br. s, 18-H3).
Methanolysis and Silylation: 4 mg of ectyoplaside A (1) was dis-
solved in 1 HCl in 85% MeOH and the solution was heated at
70°C in a stoppered reaction vial for 2 h. After cooling, the reac-
tion mixture was neutralized with Ag2CO3, centrifuged, and the
supernatant was concentrated to dryness under N2. The residue
25
was then partitioned between water (2 ϫ 5 mL) and CHCl3 (2 ϫ Ectyoplaside B (2): White, amorphous solid. Ϫ [α]D ϭ Ϫ12 (c ϭ
5 mL) yielding a polar layer (fraction A, 2.2 mg) and an apolar
layer (fraction B, 2.0 mg). Fraction B was not analyzed further,
whereas fraction A was divided into two portions. The first of these
(0.8 mg) was dissolved in TRISIL Z (0.15 mL, N-trimethylsilylimi-
0.002 in MeOH). Ϫ IR (KBr): ν˜ ϭ 3500, 2914, 1635, 1573, 1454,
1348, 1261 cmϪ1. Ϫ 1H and 13C NMR (CD3OD): See Tables 1 and
2. Ϫ FABMS (positive ions, glycerol/thioglycerol matrix); m/z: 969.
Ϫ FABMS (negative ions, thioglycerol matrix); m/z: 967, 945. Ϫ
dazole in pyridine, Pierce Chemical Co.), the solution was left at HRFABMS (positive ions); m/z: 969.4590 [MϪ ϩ Naϩ ϩ Hϩ];
35°C for 15 min, and then analyzed by GC MS. Peaks obtained
for this mixture exhibited the same retention times and the same
mass spectra as those obtained from the standard persilylated
methyl glycosides of galactose and arabinose, prepared in the
same manner.
calcd. for C46H74O20Na: 969.4670. Ϫ HRFABMS (negative ions);
m/z: 967.4500 [MϪ ϩ Naϩ Ϫ Hϩ]; calcd. for C46H72O20Na:
967.4512; m/z: 945.4691 [MϪ]; calcd. for C46H73O20: 945.4701.
Ectyoplaside B Undecaacetate (2a): 2.0 mg of ectyoplaside B (2)
was peracetylated with Ac2O/pyridine at room temperature for 12
h, yielding 2.4 mg of ectyoplaside B undecaacetate (2a) as a color-
p-Bromobenzoylation and CD: A second portion of fraction A (1.4
mg) was dissolved in dry pyridine (1.5 mL) and treated with p-
bromobenzoyl chloride (20 mg) and a catalytic amount of 4-(di-
methylamino)pyridine. The mixture was stirred overnight at 60°C,
cold water was then added, and after 30 min, the mixture was ex-
tracted with CHCl3. The obtained extract was washed successively
with saturated aqueous NaHCO3 and water, and then the solvent
was evaporated under reduced pressure. The benzoate mixture thus
obtained was separated by HPLC: Whatman Partisil PXS M9 col-
umn, eluent n-hexane/diethyl ether (85:15), UV detector (λ ϭ 260
nm). Only two major peaks were collected.
25
1
less, amorphous oil. Ϫ [α]D ϭ Ϫ15 (c ϭ 0.002 in CHCl3). Ϫ H
NMR (CDCl3, J in Hz): δ ϭ 5.45 (d, J ϭ 3.2, 1ЈЈ-H), 5.40 (d, J ϭ
3.1, 4ЈЈЈ-H), 5.28 (br. s, 4Ј-H), 5.22 (t, J ϭ 8.1, 2ЈЈЈ-H), 5.05 (24-H,
overlapped), 4.95 (d, J ϭ 7.3, 3Ј-H), 4.94 (dd, J ϭ 8.1, 3.1, 3ЈЈЈ-H),
4.93 (22-H, overlapped), 4.85 (dd, J ϭ 9.8, 3.2, 2ЈЈ-H), 4.82 (d, J ϭ
12.9, 29a-H), 4.71 (br. d, J ϭ 9.8, 3ЈЈ-H), 4.46 (d, J ϭ 8.1, 1Ј-H),
4.46 (d, J ϭ 8.1, 1ЈЈЈ-H), 4.38 (br. s, 4ЈЈ-H), 4.22 (dd, J ϭ 10.7, 6.0,
6Јa-H), 4.16 (d, J ϭ 12.9, 29b-H), 4.08 (d, J ϭ 6.3, 6ЈЈЈa-H and
6ЈЈЈb-H), 4.05 (dd, J ϭ 10.7, 6.0, 6Јb-H), 4.02 (dd, J ϭ 8.1, 7.3, 2Ј-
H), 3.89 (3-H, overlapped), 3.87 (t, J ϭ 6.3, 5ЈЈЈ-H), 3.78 (t, J ϭ
6.0, 5Ј-H), 3.50 (br. s, 5ЈЈ-H2), 2.52 (br. dd, J ϭ 11.4, 11.0, 2ax-H),
2.30 (m, 23a-H), 2.15Ϫ1.95 (11 s, 11 CH3CO signals), 2.15 (23b-
H, overlapped), 2.11 (7ax-H, overlapped), 2.10 (11-H2, overlapped),
2.05 (7eq-H, overlapped), 1.96 (15a-H, overlapped), 1.95 (12eq-H,
overlapped), 1.88 (2eq-H, overlapped), 1.88 (6ax-H, overlapped),
1.85 (16a-H, overlapped), 1.80 (1ax-H, overlapped), 1.69 (br. s, 27-
H3), 1.60 (br. s, 26-H3), 1.58 (6eq-H, overlapped), 1.58 (15b-H,
overlapped), 1.55 (dd, J ϭ 6.6, 5.7, 20-H), 1.53 (5-H, overlapped),
1.38 (dd, J ϭ 10.3, 8.2, 12ax-H), 1.31 (16b-H, overlapped), 1.25
(17-H, overlapped), 1.22 (1eq-H, overlapped), 1.04 (br. s, 19-H3),
0.98 (d, J ϭ 6.6, 21-H3), 0.58 (br. s, 18-H3). Ϫ FABMS (positive
ions, CsI ions, glycerol matrix); m/z: 1431 [MϪ ϩ Naϩ ϩ Hϩ].
Methyl
2,3,4,6-Tetra-O-(p-bromobenzoyl)-α--galactopyranoside
(3): EIMS; m/z: 926. Ϫ 1H NMR (CDCl3): δ ϭ 7.92, 7.85, 7.82,
7.63, 7.61, 7.57, 7.53, 7.39 (8 d, J ϭ 8.8 Hz, each 2 H, ArH), 5.97
(d, J ϭ 3.5 Hz, 1 H, 4-H), 5.90 (dd, J ϭ 10.5 and 3.5 Hz, 1 H, 3-
H), 5.60 (dd, J ϭ 10.5 and 3.5 Hz, 1 H, 2-H), 5.28 (d, J ϭ 3.5 Hz,
1 H, 1-H), 4.58 (m, 2 H, 5-H and 6a-H), 4.37 (m, 1 H, 6b-H). Ϫ
CD (CH3CN): ∆ε236 ϭ Ϫ30.0, ∆ε254 ϭ ϩ65.2; A ϭ ϩ90.5.
Methyl 2,3,4-Tri-O-(p-bromobenzoyl)-β--arabinopyranoside (4):
1
EIMS; m/z: 713. Ϫ H NMR (CDCl3): δ ϭ 8.03, 7.88, 7.82, 7.69,
7.59, 7.57, 7.19 (each 2 H, ArH), 5.93 (dd, J ϭ 10.5 and 3.5 Hz, 1
H, 3-H), 5.77 (d, J ϭ 3.5 Hz, 1 H, 4-H), 5.70 (dd, J ϭ 10.5 and
3.5 Hz, 1 H, 2-H), 5.21 (d, J ϭ 6.5 Hz, 1 H, 1-H), 4.18 (d, J ϭ
12.5 Hz, 1 H, 5a-H), 3.97 (d, J ϭ 12.5 Hz, 1 H, 5b-H). Ϫ CD
(CH3CN): ∆ε236 ϭ Ϫ33.1, ∆ε254 ϭ ϩ100.2; A ϭ ϩ135.5.
Bioassays, Cells and Materials: WEHI164 cells (murine fibrosar-
coma cell line) were maintained in adhesion on Petri dishes with
DulbeccoЈs Modified EagleЈs Medium (DMEM) supplemented
with 10% heat-inactivated fetal bovine serum (FBS), 25 m
HEPES, penicillin (100 U/mL) and streptomycin (100 µg/mL). J774
cells (murine monocyte/macrophage cell line) were grown in sus-
pension culture, in Techne stirrer bottles spun at 25 rpm and incu-
bated at 37°C, in DMEM medium supplemented with 10% FBS,
25 m Hepes, glutamine (2 m), penicillin (100 U/mL) and strepto-
mycin (100 µg/mL). P388 cells (murine leukemia cell line) were
grown in adhesion on Petri dishes with L-15 (Leibovitz) medium
supplemented with 10% FBS, 25 m HEPES, penicillin (100 U/
mL) and streptomycin (100 µg/mL). All reagents for cell culture
were purchased from Cellbio; MTT [3-(4,5-dimethylthiazol-2-yl)-
2,5-phenyl-2H-tetrazolium bromide] and 6-mercaptopurine were
obtained from Sigma.
Enzymatic Hydrolysis: A solution of ectyoplaside A (1, 5 mg) in
phosphate/citrate buffer (1.5 mL) at pH ϭ 5.0 was incubated with
10 mg of glycosidase mixture from Charonia lampas (Scikagaku
kogyo) at 38°C for ca. 72 h. The mixture was then neutralized,
filtered, and the filtrate was partitioned between H2O and CHCl3.
The aqueous layer was concentrated to dryness and the residue was
found to contain salts, the unreacted saponin, and a mixture of
partial glycosides. The organic extract was dried with Na2SO4, fil-
tered, and concentrated in vacuo, to afford a fraction which was
shown to contain compound 5 (ca. 0.3 mg).
Compound 5: Colorless, amorphous oil. HRFABMS (positive ions,
glycerol matrix); m/z: 475.3430 [M ϩ Hϩ]; calcd. for C29H47O5:
1
475.3421. Ϫ H NMR (CD3OD): δ ϭ 5.15 (br. t, J ϭ 9.5, 24-H),
3.67 (dd, J ϭ 7.8, 5.6, 22-H), 3.21 (br. d, J ϭ 11.0, 3-H), 2.61 (br.
dd, J ϭ 10.1, 9.2, 2ax-H), 2.20 (11ax-H, overlapped), 2.17 (23a-H,
overlapped), 2.16 (11eq-H, overlapped), 2.12 (23b-H, overlapped),
Cytotoxic Activity: WEHI164, J774, P388 (4 ϫ 103 cells) were
placed in 96-well plates and allowed to adhere at 37°C in 5% CO2/
95% air for 2 h. Thereafter, the medium was replaced with 50 µL
Eur. J. Org. Chem. 1999, 231Ϫ238
237